Forgot your account information?  |  Create a CME account

Pfizer Canada provides $4.5 million public research funding for Alzheimer’s Disease

Published by Stephanie Brooks on June 28, 2012

Pfizer Canada and the Fonds de recherche du Québec – Santé (FRQS) are announcing today a Pfizer-FRQS Innovation Fund for Alzheimer’s Disease and Related Disorders, as a result of $4.5 million worth of funding from Pfizer Canada. 

The research grant program will be available to Quebec’s research community and will foster innovative research for better understanding the mechanisms underlying the disease.

Please see Pfizer’s press release here. 

Found in: news cmenews

National Office

Alberta British Columbia
Manitoba New Brunswick
Newfoundland & Labrador Nova Scotia
Ontario Québec
Prince Edward Island Saskatchewan